Liquid Biomarkers and MRI in Prostate Cancer – Complementary?
Sanoj Punnen, MD, MAS, discusses the complementary use of liquid biomarkers and magnetic resonance imaging (MRI) in prostate cancer diagnosis.
Read MoreSelect Page
Posted by Sanoj Punnen, MD, MAS | Mar 2023
Sanoj Punnen, MD, MAS, discusses the complementary use of liquid biomarkers and magnetic resonance imaging (MRI) in prostate cancer diagnosis.
Read MorePosted by Marc B. Garnick, MD | Mar 2023
E. David Crawford, MD, and Marc B. Garnick, MD, discuss cardiovascular complications in patients on androgen deprivation therapy (ADT).
Read MorePosted by Thomas M. Wheeler, MD | Mar 2023
Thomas M. Wheeler, MD, provides an anatomic perspective of prostate cancer diagnosis and movement prediction.
Read MorePosted by Larry I. Lipshultz, MD | Mar 2023
Larry I. Lipshultz, MD, discusses epigenetic testing for male fertility management and the treatment implications for men with infertility.
Read MorePosted by Neil H. Baum, MD | Feb 2023
Neil H. Baum, MD, interviews Abraham Morgentaler, MD, FACS, on his clinical research treating men using testosterone therapy.
Read More